Antibiotic use and risk of myocardial infarction [1] (multiple letters)

JAMA

Volumn 282, Issue 21, 1999, Pages 1997-1999

  Haider, A W ^a   Luna, M ^a   Patel, S ^a   Gaziano, J M ^a   Glenn, L ^a   Golub, L M ^a   Greenwald, R A ^a   Thompson, R W ^a   Hahn, D L ^a   Hammerschlag, M R ^a   Meier, C R ^a   Derby, L E ^a   Jick, S S ^a   Vasilakis, C ^a   Jick, H ^a  

^a Carney Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; 4 QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; AUTACOID; MATRIX METALLOPROTEINASE;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CARDIOVASCULAR RISK; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; LETTER; PRIORITY JOURNAL; DRUG ANTAGONISM; DRUG EFFECT; NOTE; RISK; MICROBIOLOGY;

4-QUINOLONES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; HUMANS; INFLAMMATION MEDIATORS; MATRIX METALLOPROTEINASES; MYOCARDIAL INFARCTION; RISK; TETRACYCLINES;

EID: 0033482233     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.21.1997     Document Type: Letter

References (0)